We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NEUROBIOLOGICAL TECHNOLOGIES, INC. RECEIVES $4 MILLION MILESTONE PAYMENT FROM CELTIC PHARMA FOR XERECEPT
NEUROBIOLOGICAL TECHNOLOGIES, INC. RECEIVES $4 MILLION MILESTONE PAYMENT FROM CELTIC PHARMA FOR XERECEPT
June 19, 2006
Neurobiological Technologies, Inc. today announced it has received $4 million from Celtic Pharmaceutical Holdings L.P. (Celtic Pharma) as part of Neurobiological Technologies' previously announced sale of worldwide rights to Celtic Pharma for Xerecept, a Phase III clinical compound for the treatment of peritumoral brain edema. Yahoo News
